Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. CommentaryLÖFDAHL, C.-G; REISS, T. F; BERGER, A et al.BMJ. British medical journal (International ed.). 1999, Vol 319, Num 7202, pp 87-90, issn 0959-8146Article

Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trialKNORR, B; MATZ, J; BERNSTEIN, J. A et al.JAMA, the journal of the American Medical Association. 1998, Vol 279, Num 15, pp 1181-1186, issn 0098-7484Article

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthmaKEMP, J. P; DOCKHORN, R. J; SHAPIRO, G. G et al.The Journal of pediatrics. 1998, Vol 133, Num 3, pp 424-428, issn 0022-3476Article

The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthmaDIAMANT, Z; GROOTENDORST, D. C; VESELIC-CHARVAT, M et al.Clinical and experimental allergy (Print). 1999, Vol 29, Num 1, pp 42-51, issn 0954-7894Article

Validation of an asthma symptom diary for interventional studiesSANTANELLO, N. C; DAVIES, G; GALANT, S. P et al.Archives of disease in childhood. 1999, Vol 80, Num 5, pp 414-420, issn 0003-9888Article

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain : A randomized, placebo- and active-comparator-controlled clinical trialMALMSTROM, K; DANIELS, S; KOTEY, P et al.Clinical therapeutics. 1999, Vol 21, Num 10, pp 1653-1663, issn 0149-2918Article